What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
His primary areas of investigation include Pulmonary hypertension, Internal medicine, Respiratory disease, Anesthesia and Endocrinology.
His research in Pulmonary hypertension intersects with topics in Iloprost, Sildenafil, Vascular resistance, Lung and Pulmonary artery.
His Lung research includes themes of Hypoxia and Pharmacology.
His studies deal with areas such as Gastroenterology, Biochemistry, Surgery and Cardiology as well as Internal medicine.
His biological study spans a wide range of topics, including Oxidative stress and Bronchoalveolar lavage.
His work carried out in the field of Endocrinology brings together such families of science as BMPR2, Gene expression and Obstructive sleep apnea.
His most cited work include:
- Sildenafil citrate therapy for pulmonary arterial hypertension. (1945 citations)
- Reversal of experimental pulmonary hypertension by PDGF inhibition. (874 citations)
- Riociguat for the Treatment of Pulmonary Arterial Hypertension (762 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Pulmonary hypertension, Cardiology, Lung and Pharmacology.
His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology and Surgery.
His Pulmonary hypertension research integrates issues from Anesthesia, Hypoxia, Pathology, Vascular resistance and Pulmonary artery.
His Anesthesia study combines topics in areas such as Respiratory disease and Iloprost.
The various areas that Friedrich Grimminger examines in his Cardiology study include Sildenafil and Blood pressure.
His Pharmacology research incorporates themes from Biochemistry, Immunology and Vasodilation.
He most often published in these fields:
- Internal medicine (43.76%)
- Pulmonary hypertension (42.28%)
- Cardiology (21.78%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (43.76%)
- Pulmonary hypertension (42.28%)
- Cardiology (21.78%)
In recent papers he was focusing on the following fields of study:
Friedrich Grimminger mainly focuses on Internal medicine, Pulmonary hypertension, Cardiology, Cancer research and Riociguat.
His Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Surgery.
The Surgery study combines topics in areas such as Sildenafil and Treprostinil.
Friedrich Grimminger interconnects Ventricular pressure, Pathology, COPD, Lung and Pulmonary artery in the investigation of issues within Pulmonary hypertension.
His work deals with themes such as Anesthesia, Blood pressure, MEDLINE and Hazard ratio, which intersect with Cardiology.
His Riociguat research includes elements of Gastroenterology, Tolerability and Clinical endpoint.
Between 2013 and 2021, his most popular works were:
- Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension (156 citations)
- Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2) (142 citations)
- Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2) (100 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Internal medicine, Pulmonary hypertension, Cardiology, Cancer research and Pathology are his primary areas of study.
The various areas that Friedrich Grimminger examines in his Internal medicine study include Endocrinology and Surgery.
Friedrich Grimminger usually deals with Surgery and limits it to topics linked to Vascular resistance and Cardiac index.
His work deals with themes such as Inflammation, COPD, Lung, Disease and Hemodynamics, which intersect with Pulmonary hypertension.
His Cancer research research is multidisciplinary, relying on both Hypoxia, Cancer cell, Immunology, Metastasis and Idiopathic pulmonary fibrosis.
Friedrich Grimminger combines subjects such as Muscle hypertrophy and Immune system with his study of Pathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
